MYC |
AP-1 transcription factor network |
pid |
71 |
MYC |
Binding of TCF/LEF:CTNNB1 to target gene promoters |
reactome |
7 |
MYC |
C-MYB transcription factor network |
pid |
87 |
MYC |
C-MYC pathway |
pid |
25 |
MYC |
CD40/CD40L signaling |
pid |
36 |
MYC |
Ceramide signaling pathway |
pid |
49 |
MYC |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants |
reactome |
57 |
MYC |
Constitutive Signaling by NOTCH1 PEST Domain Mutants |
reactome |
57 |
MYC |
Cyclin A:Cdk2-associated events at S phase entry |
reactome |
15 |
MYC |
Cyclin E associated events during G1/S transition |
reactome |
14 |
MYC |
E2F transcription factor network |
pid |
77 |
MYC |
EGFR1 |
netpath |
475 |
MYC |
Formation of the beta-catenin:TCF transactivating complex |
reactome |
88 |
MYC |
FOXM1 transcription factor network |
pid |
43 |
MYC |
IL2-mediated signaling events |
pid |
54 |
MYC |
IL2 signaling events mediated by PI3K |
pid |
38 |
MYC |
IL2 signaling events mediated by STAT5 |
pid |
30 |
MYC |
IL6-mediated signaling events |
pid |
48 |
MYC |
Interleukin signaling pathway |
panther |
86 |
MYC |
LKB1 signaling events |
pid |
43 |
MYC |
MAPK6/MAPK4 signaling |
reactome |
90 |
MYC |
Notch signaling pathway |
pid |
58 |
MYC |
NOTCH1 Intracellular Domain Regulates Transcription |
reactome |
47 |
MYC |
Oxidative stress response |
panther |
23 |
MYC |
p53 pathway feedback loops 2 |
panther |
42 |
MYC |
p73 transcription factor network |
pid |
80 |
MYC |
PDGF signaling pathway |
panther |
113 |
MYC |
PDGFR-beta signaling pathway |
pid |
125 |
MYC |
Presenilin action in Notch and Wnt signaling |
pid |
46 |
MYC |
Prolactin |
netpath |
105 |
MYC |
Regulation of nuclear beta catenin signaling and target gene transcription |
pid |
80 |
MYC |
Regulation of nuclear SMAD2/3 signaling |
pid |
82 |
MYC |
Regulation of Telomerase |
pid |
70 |
MYC |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
reactome |
32 |
MYC |
TGF_beta_Receptor |
netpath |
220 |
MYC |
Validated nuclear estrogen receptor alpha network |
pid |
65 |
MYC |
Validated targets of C-MYC transcriptional activation |
pid |
80 |
MYC |
Validated targets of C-MYC transcriptional repression |
pid |
63 |
MYC |
MAPK signaling pathway |
kegg |
264 |
MYC |
ErbB signaling pathway |
kegg |
83 |
MYC |
Cell cycle |
kegg |
124 |
MYC |
Wnt signaling pathway |
kegg |
135 |
MYC |
TGF-beta signaling pathway |
kegg |
82 |
MYC |
Jak-STAT signaling pathway |
kegg |
149 |
MYC |
Pathways in cancer |
kegg |
321 |
MYC |
Colorectal cancer |
kegg |
63 |
MYC |
Endometrial cancer |
kegg |
52 |
MYC |
Thyroid cancer |
kegg |
25 |
MYC |
Bladder cancer |
kegg |
38 |
MYC |
Chronic myeloid leukemia |
kegg |
69 |
MYC |
Acute myeloid leukemia |
kegg |
53 |
MYC |
Small cell lung cancer |
kegg |
83 |
MYC |
Hs_DNA_Damage_Response_(only_ATM_dependent)_WP710_79974 |
wikipathways |
36 |
MYC |
Hs_TP53_Network_WP1742_71700 |
wikipathways |
10 |
MYC |
Hs_Imatinib_and_Chronic_Myeloid_Leukemia_WP3640_89384 |
wikipathways |
11 |
MYC |
Hs_miRNAs_involved_in_DNA_damage_response_WP1545_84697 |
wikipathways |
30 |
MYC |
Hs_Association_Between_Physico-Chemical_Features_and_Toxicity_Associated_Pathways_WP3680_90113 |
wikipathways |
31 |
MYC |
Hs_Gastric_Cancer_Network_2_WP2363_87523 |
wikipathways |
28 |
MYC |
Hs_Hepatitis_C_and_Hepatocellular_Carcinoma_WP3646_88640 |
wikipathways |
36 |
MYC |
Hs_Apoptosis_WP254_88977 |
wikipathways |
31 |
MYC |
Hs_Integrated_Breast_Cancer_Pathway_WP1984_82941 |
wikipathways |
122 |
MYC |
Hs_Neural_Crest_Differentiation_WP2064_79263 |
wikipathways |
40 |
MYC |
Hs_IL-5_Signaling_Pathway_WP127_78498 |
wikipathways |
35 |
MYC |
Hs_Prolactin_Signaling_Pathway_WP2037_90015 |
wikipathways |
52 |
MYC |
Hs_EGF-EGFR_Signaling_Pathway_WP437_79266 |
wikipathways |
107 |
MYC |
Hs_IL-7_Signaling_Pathway_WP205_89854 |
wikipathways |
16 |